Burnley-Moran and Johnson elementary schools in Charlottesville will have new names at the start of the next school year.

Matternet, the developer of the world's leading urban drone delivery system, today announced that the company has been approved by The Kingdom of Saudi Arabia to operate its M2 drone within the region ...

Redwood City and Boston-based Adicet Bio ... formed a collaboration with Sarepta to develop therapies for neuromuscular diseases, which included $57 million in near-term payments.

We recently published an article titled Jim Cramer’s Lightning Rounds: 9 Stocks in Focus. In this article, we are going to ...

Tazeen Ahmad, an analyst from Bank of America Securities, maintained the Buy rating on Sarepta Therapeutics (SRPT – Research Report). The associated price target remains the same with $217.00.

Analyst Gil Blum from Needham maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report) and keeping the price target at $202.00. Gil Blum has given his Buy rating due to a ...

No new safety signals were observed. As part of a collaboration agreement signed in 2019, Sarepta is working with Roche Holdings AG RHHBY. Sarepta is responsible for regulatory approval and ...

Hello, and thank you for standing by. My name is Bella, and I will be your conference operator today. At this time, I would like to welcome everyone to ConnectOne Bancorp, Inc. fourth quarter 2024 ...

Sarepta's EMBARK study confirms Elevidys offers sustained Duchenne treatment benefits, including motor function improvement and minimal muscle pathology progression. Solid Biosciences advances ...

Sarepta is currently testing SRP-9001 in the placebo-controlled EMBARK study, which aims to enrol 120 boys with DMD aged four to seven and is due to read out in the latter half of 2023.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...